Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion

• Status: Completed
• Trial end date: 2009-05-01
• Target enrollment: 0
• Participant gender: All

Summary

Blinded study using oral gabapentin in load pre-operative (15mg/kg) and maintenance 5mg/kg three times a day (TID) for 5 days or discharge, Patient Controlled Analgesia (PCA) morphine and placebo group with similar pills, also PCA morphine. The goal is to measure morphine usage and incidence of morphine side effects (pruritis, days foley, days to first stool, sedation, pain scores, PCA use).

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical College of Wisconsin
• Collaborator: Children's Hospital and Health System Foundation, Wisconsin
• Treatments: Gabapentin; gamma-Aminobutyric Acid; Morphine; Narcotics

Criteria

Inclusion Criteria:

• ASA 1-2, Idiopathic Scoliosis

Exclusion Criteria:

• ASA 3 or greater

• Neuromuscular scoliosis

• On narcotics baseline